Table 1. Characteristics of participants with and without CMBs.
| Characteristics | Non-CMBs (n=446) | CMBs location | |
|---|---|---|---|
| Deep/mixed (n=55) | Lobar (n=48) | ||
| Age, mean (SD), years | 59.02 (2.72) | 59.71 (2.57) | 60.12 (2.56)* |
| Women, n (%) | 233 (52.2) | 33 (60.0) | 33 (68.8) |
| BMI, mean (SD) | 24.13 (3.32) | 24.45 (3.96) | 23.45 (2.16) |
| Smoking#, n (%) | 162 (36.7) | 18 (33.3) | 11 (22.9) |
| Alcohol drinking#, n (%) | 133 (30.3) | 15 (27.8) | 11 (22.9) |
| Hypertension, n (%) | 235 (52.7) | 38 (69.1)* | 32 (66.7) |
| Diabetes, n (%) | 61 (13.7) | 9 (16.4) | 3 (6.3) |
| Hyperlipidemia, n (%) | 216 (48.4) | 27 (49.1) | 21 (43.8) |
| ALDH2 genotype (rs671)*, n (%) | |||
| *1/*1 | 249 (55.8) | 42 (76.4) | 31 (64.6) |
| *1/*2 | 173 (38.8) | 10 (18.2) | 16 (33.3) |
| *2/*2 | 24 (5.4) | 3 (5.5) | 1 (2.1) |
#, 5 subjects had missing data for smoking and drinking status; *, P<0.05 (compared with non-CMBs group). CMBs, cerebral microbleeds; SD, standard deviation; BMI, body mass index; ALDH2, aldehyde dehydrogenase 2.